These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 14630261

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatment.
    Buyyounouski MK, Horwitz EM, Price RA, Hanlon AL, Uzzo RG, Pollack A.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):743-9. PubMed ID: 14967429
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pelvic organ motion and dosimetric implications during horizontal patient rotation for prostate radiation therapy.
    Buckley JG, Dowling JA, Sidhom M, Liney GP, Rai R, Metcalfe PE, Holloway LC, Keall PJ.
    Med Phys; 2021 Jan 01; 48(1):397-413. PubMed ID: 33151543
    [Abstract] [Full Text] [Related]

  • 27. Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer.
    Martinez AA, Yan D, Lockman D, Brabbins D, Kota K, Sharpe M, Jaffray DA, Vicini F, Wong J.
    Int J Radiat Oncol Biol Phys; 2001 Aug 01; 50(5):1226-34. PubMed ID: 11483333
    [Abstract] [Full Text] [Related]

  • 28. Influence of organ at risk definition on rectal dose-volume histograms in patients with prostate cancer undergoing external-beam radiotherapy.
    Boehmer D, Kuczer D, Badakhshi H, Stiefel S, Kuschke W, Wernecke KD, Budach V.
    Strahlenther Onkol; 2006 May 01; 182(5):277-82. PubMed ID: 16673061
    [Abstract] [Full Text] [Related]

  • 29. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
    Nitsche M, Brannath W, Brückner M, Wagner D, Kaltenborn A, Temme N, Hermann RM.
    Br J Radiol; 2017 Feb 01; 90(1070):20160370. PubMed ID: 27936891
    [Abstract] [Full Text] [Related]

  • 30. IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.
    van Lin EN, Fütterer JJ, Heijmink SW, van der Vight LP, Hoffmann AL, van Kollenburg P, Huisman HJ, Scheenen TW, Witjes JA, Leer JW, Barentsz JO, Visser AG.
    Int J Radiat Oncol Biol Phys; 2006 May 01; 65(1):291-303. PubMed ID: 16618584
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N, Jamalludin Z, Ung NM, Ho GF, Malik RA, Phua VC.
    Asian Pac J Cancer Prev; 2014 May 01; 15(13):5259-64. PubMed ID: 25040985
    [Abstract] [Full Text] [Related]

  • 33. Emptying the rectum before treatment delivery limits the variations of rectal dose - volume parameters during 3DCRT of prostate cancer.
    Stasi M, Munoz F, Fiorino C, Pasquino M, Baiotto B, Marini P, Malinverni G, Valdagni R, Gabriele P.
    Radiother Oncol; 2006 Sep 01; 80(3):363-70. PubMed ID: 16959344
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.
    Ghilezan M, Yan D, Liang J, Jaffray D, Wong J, Martinez A.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1602-10. PubMed ID: 15590192
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Sensitivity of treatment plan optimisation for prostate cancer using the equivalent uniform dose (EUD) with respect to the rectal wall volume parameter.
    Schwarz M, Lebesque JV, Mijnheer BJ, Damen EM.
    Radiother Oncol; 2004 Nov 01; 73(2):209-18. PubMed ID: 15542168
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.